Jonathon Johnson, who previously appeared on Jenn Tran's season of The Bachelorette, is heading to Bachelor in Paradise with a clean slate and an open mind. He's hoping to avoid any pre-existing drama or pressure and get to know the cast members authentically. Johnson explains that he's grown since his last appearance and is looking for someone who can handle the unique lifestyle that comes with being on the show.
Jonathon Johnson may have an idea of what he’s looking for on Bachelor in Paradise, but he’s keeping his options open.
Johnson shared that he hoped to enter the spinoff show with a “clean slate and an open mind,” adding his mindset would be “whoever is here, is here.” “I’ve done a lot of growing up since then in what I want and what I need,” Johnson explained. “I think in this world, a lot of people get lost in the sauce a little bit or drink the Kool-Aid, whatever you want to say. I want somebody who this life and this energy doesn't affect. Like, I want them to be on it because it's a fun, cool, experience but like is just a very real person and doesn't take life too serious because I don't.
BACHELOR IN PARADISE JONATHON JOHNSON DATING REALITY TV LOVE
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Jonathon Johnson Defends Excluding From Next Bachelor RoleJonathon Johnson reveals he wasn't considered for the next Bachelor role, despite speculation. He expresses his happiness for his friend Grant Ellis, who takes on the lead position. Johnson says he has stayed in touch with Ellis but avoids discussing the season details out of respect. Both Johnson and host Jesse Palmer confirm that Grant's journey to find love was particularly challenging due to the strong group of women he met.
Read more »
Aaron Taylor-Johnson and Sam Taylor-Johnson Celebrate End of 2024 with Romantic GetawayAaron Taylor-Johnson and his wife Sam Taylor-Johnson shared photos of their romantic vacation, showcasing intimate moments and breathtaking scenery. Aaron also shared shirtless photos, highlighting his physique.
Read more »
Johnson & Johnson's Lung Cancer Drugs Show Longer Survival Than AstraZeneca's TagrissoA clinical trial shows J&J's combination therapy extending survival for at least a year longer than Tagrisso. This breakthrough could change the treatment landscape for non-small cell lung cancer with EGFR mutations.
Read more »
Johnson & Johnson's Lung Cancer Drug Combo Shows Longer SurvivalJohnson & Johnson (J&J) announced that a combination of its lung cancer drugs, Rybrevant and Lazcluze, extended survival by at least a year compared to AstraZeneca's Tagrisso in a clinical trial. J&J aims to challenge Tagrisso's dominance as a leading treatment for non-small cell lung cancer with EGFR mutations.
Read more »
Johnson & Johnson Stock Hits Four-Year Low Amidst Rate Cut DoubtsJohnson & Johnson (JNJ) stock dropped to its lowest point in over four years on Wednesday, coinciding with a broader market decline fueled by expectations that the Federal Reserve may pause interest rate cuts due to a robust US labor market. Recent economic data, including strong job market indicators and an expanding services sector, have led investors to anticipate the Fed maintaining current interest rates. This development comes as JNJ received Fast Track status from the FDA for its Alzheimer's drug, posdinemab.
Read more »
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 BillionJohnson & Johnson unveils a major acquisition, purchasing Intra-Cellular Therapies for $14.6 billion to bolster its central nervous system disorder treatment portfolio. The deal focuses on Caplyta, a promising drug for schizophrenia and depression, with strong anticipated growth.
Read more »